Growth Metrics

Damora Therapeutics (DMRA) Prepaid Assets (2019 - 2026)

Damora Therapeutics posted quarterly Prepaid Assets of $2.5 million for Q1 2026, up 507.51% year-on-year from $413000.0 in Q1 2025, and up 334.84% on a QoQ basis from $577000.0 in Q4 2025.

Damora Therapeutics (DMRA) has 8 years of Prepaid Assets data on file, last reported at $2.5 million in Q1 2026.

  • For the quarter ending Q1 2026, Prepaid Assets rose 507.51% year-over-year to $2.5 million; the trailing twelve-month figure through Mar 2026 stood at $2.5 million (up 507.51% YoY), and the FY2025 full-year result was $577000.0, down 2.2% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $2.5 million, up from $577000.0 in the prior quarter.
  • Across five years, Prepaid Assets topped out at $3.9 million in Q1 2023 and bottomed at $52000.0 in Q4 2022.
  • The 5-year median for Prepaid Assets is $577000.0 (2025), against an average of $1.3 million.
  • The widest annual swing landed in 2023, when Prepaid Assets surged 1446.22%; it then sank 96.91% in 2024.
  • A 5-year view of Prepaid Assets shows it stood at $52000.0 in 2022, then soared by 1388.46% to $774000.0 in 2023, then decreased by 23.77% to $590000.0 in 2024, then fell by 2.2% to $577000.0 in 2025, then surged by 334.84% to $2.5 million in 2026.
  • The last three Prepaid Assets figures came in at $2.5 million (Q1 2026), $577000.0 (Q4 2025), and $56000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,216,509.61 Bn 1,216,509.61 Bn -
2 Alterity Therapeutics 764,224.41 Bn 764,224.38 Bn -
3 Legend Biotech 2,716.00 Bn 2,715.71 Bn 242.10 Mn
4 Nanobiotix 2,248.83 Bn 2,248.77 Bn -
5 Akari Therapeutics 1,951.18 Bn 1,951.17 Bn -
6 Vertex Pharmaceuticals 113.69 Bn 106.44 Bn 2.59 Bn
7 Evaxion A 64.16 Bn 64.14 Bn -
8 Regeneron Pharmaceuticals 63.94 Bn 55.18 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 40.13 Bn 37.12 Bn 959.66 Mn
10 Damora Therapeutics 853.36 Mn 650.97 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 2.51 Mn
Dec 31, 2025 577,000.00
Sep 30, 2025 56,000.00
Jun 30, 2025 232,000.00
Mar 31, 2025 413,000.00
Dec 31, 2024 590,000.00
Sep 30, 2024 89,000.00
Jun 30, 2024 2.31 Mn
Mar 31, 2024 189,000.00
Dec 31, 2023 774,000.00
Sep 30, 2023 2.88 Mn
Jun 30, 2023 3.24 Mn
Mar 31, 2023 3.88 Mn
Dec 31, 2022 52,000.00
Sep 30, 2022 214,000.00
Jun 30, 2022 3.18 Mn
Mar 31, 2022 251,000.00
Dec 31, 2021 334,000.00
Sep 30, 2021 4.86 Mn
Jun 30, 2021 665,000.00
Mar 31, 2021 6.57 Mn
Dec 31, 2020 242,000.00
Sep 30, 2020 5.34 Mn
Dec 31, 2019 5.12 Mn